There are actually good physiologic reasons that may account for why HBOT can have useful outcomes on selected ocular health conditions. Corneal edema with many etiologies and anterior phase ischemia, specially when connected with sickle-mobile anemia, seem to be a correct indication for HBOT.OPDIVO® (nivolumab) is actually a prescription medicine